ASX:LTPPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
LTR Pharma Ltd
$0.465
+$0.015 (+3.33%)
Day Range
$0.465 – $0.495
52 Week Range
$0.315 – $0.810
Volume
50.65K
Avg Volume (10D)
182.29K
Market Cap
$84.53M
Price Chart
Market Statistics
Open$0.470
Previous Close$0.450
Day High$0.495
Day Low$0.465
52 Week High$0.810
52 Week Low$0.315
Valuation
Market Cap84.53M
Shares Outstanding181.78M
Price to Book3.14
Trading Activity
Volume50.65K
Value Traded24.15K
Bid$0.450 × 13,417
Ask$0.510 × 23,690
Performance
1 Day3.33%
5 Day-5.10%
13 Week-8.82%
52 Week36.76%
YTD-35.42%
Technical Indicators
RSI (14)43.60
50-Day SMA$0.489
200-Day SMA$0.486
Latest News
Biotechnology
LTR Pharma Executes US Commercialisation Agreement with Shed DTC Platform
LTR Pharma inks US ROXUS deal with Shed; targets 150k units in year one via Mavrox telehealth—fast-acting 10-min onset.
Hot Topics
The Weekly Finger: On Green and Gold, and Oil and Gold
Oil inventories near lows despite Iran peace chatter; gold and oil diverge on the energy complex. Small Caps weekly market wrap on ASX stocks.
Biotechnology
LTR Pharma Signs Binding US Telehealth Term Sheet For ROXUS
LTR Pharma signs binding US telehealth term sheet with Shed Holdings for ROXUS via Mavrox; Definitive Agreements in 60 days to kickstart US commercialization.
Biotechnology
LTR Pharma Unveils Strong SPONTAN Data and Dual US Strategy
LTR Pharma reports SPONTAN PK: 5 mg intranasal Tmax 10 min vs 60 min oral; FDA 505(b)(2) pathway; dual US strategy; $24.1m cash, 2026 milestones